Old West Investment Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-17,592
| Closed | -$359K | – | 68 |
|
2021
Q1 | $359K | Hold |
17,592
| – | – | 0.08% | 39 |
|
2020
Q4 | $312K | Buy |
17,592
+7,504
| +74% | +$133K | 0.07% | 37 |
|
2020
Q3 | $149K | Sell |
10,088
-78
| -0.8% | -$1.15K | 0.03% | 43 |
|
2020
Q2 | $213K | Sell |
10,166
-92
| -0.9% | -$1.93K | 0.06% | 44 |
|
2020
Q1 | $237K | Sell |
10,258
-926
| -8% | -$21.4K | 0.18% | 44 |
|
2019
Q4 | $289K | Hold |
11,184
| – | – | 0.11% | 55 |
|
2019
Q3 | $217K | Sell |
11,184
-1,758
| -14% | -$34.1K | 0.13% | 54 |
|
2019
Q2 | $211K | Sell |
12,942
-86,924
| -87% | -$1.42M | 0.1% | 59 |
|
2019
Q1 | $2.26M | Sell |
99,866
-10,312
| -9% | -$234K | 0.82% | 30 |
|
2018
Q4 | $2.82M | Sell |
110,178
-1,083
| -1% | -$27.7K | 0.76% | 23 |
|
2018
Q3 | $3.63M | Buy |
111,261
+160
| +0.1% | +$5.23K | 1.5% | 20 |
|
2018
Q2 | $2.52M | Buy |
111,101
+1,781
| +2% | +$40.4K | 1.27% | 27 |
|
2018
Q1 | $2.65M | Sell |
109,320
-4,542
| -4% | -$110K | 1.53% | 24 |
|
2017
Q4 | $3.18M | Sell |
113,862
-80
| -0.1% | -$2.23K | 1.81% | 22 |
|
2017
Q3 | $3.9M | Sell |
113,942
-6,835
| -6% | -$234K | 2.05% | 20 |
|
2017
Q2 | $4.81M | Sell |
120,777
-20,397
| -14% | -$812K | 2.57% | 14 |
|
2017
Q1 | $5.2M | Buy |
141,174
+89,158
| +171% | +$3.28M | 2.76% | 12 |
|
2016
Q4 | $1.66M | Buy |
52,016
+6,362
| +14% | +$203K | 1.01% | 23 |
|
2016
Q3 | $1.65M | Buy |
45,654
+2,573
| +6% | +$93.2K | 1.2% | 24 |
|
2016
Q2 | $977K | Buy |
43,081
+4,193
| +11% | +$95.1K | 0.71% | 29 |
|
2016
Q1 | $731K | Sell |
38,888
-4,479
| -10% | -$84.2K | 0.61% | 36 |
|
2015
Q4 | $710K | Sell |
43,367
-12,759
| -23% | -$209K | 0.64% | 40 |
|
2015
Q3 | $616K | Buy |
56,126
+19,997
| +55% | +$219K | 0.47% | 46 |
|
2015
Q2 | $470K | Buy |
36,129
+16,512
| +84% | +$215K | 0.33% | 60 |
|
2015
Q1 | $340K | Sell |
19,617
-194
| -1% | -$3.36K | 0.23% | 71 |
|
2014
Q4 | $295K | Buy |
19,811
+8,850
| +81% | +$132K | 0.18% | 76 |
|
2014
Q3 | $252K | Buy |
+10,961
| New | +$252K | 0.16% | 78 |
|